Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCC

Clinical trial NCT06762808 · WITHDRAWN

Trial details

NCT number: NCT06762808
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma

Start date: 2025-05-01
Primary completion: 2025-08-08
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.